 Home > Medical News > Latest Medical News > Cinda Biotech declares that the first domestic SIRPα antibody CD47 pathway has deployed 3 new drugs

Cinda Biotech declares that the first domestic SIRPα antibody CD47 pathway has deployed 3 new drugs

 Last Update: 2021-09-11
 Source: Internet
 Author: User

Tags

tumor cells

stage pancreatic cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Author: Plus One

On September 8, Cinda Biotech declared a new type of anti-SIRP-alpha antibody IBI397 (Alector R&D code: AL008)

From: CDE official website

Dual mechanism inhibition of SIRPα/CD47 pathway

IBI397 is the first SIRP-alpha inhibitor with a unique dual mechanism and a differentiated mechanism

IBI397 single agent inhibited tumor growth and enhanced the activity of M1 macrophages in preclinical humanized mouse tumor models

At the same time, in pre-clinical studies, there was no side effect of clearing red blood cells or platelets

At present, this product has not started clinical practice at home and abroad

CD47-SIRPα: The Way of Kings

In the development of new anti-cancer drugs, the CD47-SIRPα pathway has attracted much attention

In March 2020, Gilead announced that it had acquired FortySeven Biotech, a company that focuses on the development of CD47 pathway inhibitors, for a total value of US$4.

With the blessing of Dachang, this field in China is also a red sea

Domestic CD47 antibody drug development pattern (Insight)

Cinda has already deployed 3 products for CD47-SIRPα, including CD47 monoclonal antibody IBI188 (letaplimab) and PD-L1/CD47 double antibody IBI322.

IBI188 project timeline

From: Insight database (http://db.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.